Menu Search
Equities

Episurf Medical AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
EPSFF:PNK

Episurf Medical AB

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded147.00k
  • 1 Year change--
  • Beta0.7676
Data delayed at least 15 minutes, as of Aug 05 2025 13:05 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Episurf Medical AB is a Sweden-based company primarily engaged in the medical device industry. The Company scope of activity includes developing and commercializing patient-specific implants and surgical instruments for the treatment of joint injuries, particularly in the knee and ankle. Their key product is Episealer, which is a customized implant system. It is designed to treat localized cartilage damage and early-stage osteoarthritis by adapting the implant and associated surgical tools to the individual anatomy and injury of each patient.

  • Revenue in SEK (TTM)15.60m
  • Net income in SEK-62.70m
  • Incorporated2008
  • Employees26.00
  • Location
    Episurf Medical ABKarlavagen 60STOCKHOLM 114 49SwedenSWE
  • Phone+46 86120020
  • Websitehttps://episurf.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		EPIS B:STO since
announced		Transaction
value
KlaraBo Empire Holding ABAnnounced26 Jan 202626 Jan 2026Announced73.33%40.41m
Frusipe Intressenter Target 1 ABAnnounced30 Dec 202530 Dec 2025Announced73.33%125.00m
Data delayed at least 15 minutes, as of Feb 06 2026 17:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.